(Q28165946)

https://api.crossref.org/works/10.1016/S0002-8703(03)00368-5

28 March 2024

1

Steffen Massberg

0 references

Meinrad Gawaz

5

object named as

Meinrad Gawaz

0 references

author name string

Iris Mueller

2

0 references

Felicitas Besta

3

0 references

Phillip Thomas

full work available at URL

4

0 references

language of work or name

English

0 references

publication date

November 2003

0 references

https://api.elsevier.com/content/article/PII:S0002870303003685?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(03)00368-5

https://api.elsevier.com/content/article/PII:S0002870303003685?httpAccept=text/plain

28 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(03)00368-5

Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease.

28 March 2024

published in

American Heart Journal

0 references

volume

146

0 references

issue

5

0 references

page(s)

E19

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

Blockade of Platelet GPIIb/IIIa Receptors as an Antithrombotic Strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

Abciximab (c7E3 Fab). A review of its pharmacology and therapeutic potential in ischaemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

Abciximab (ReoPro, chimeric 7E3 Fab) demonstrates equivalent affinity and functional blockade of glycoprotein IIb/IIIa and alpha(v)beta3 integrins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

7E3 monoclonal antibody directed against the platelet glycoprotein IIb/IIIa cross-reacts with the leukocyte integrin Mac-1 and blocks adhesion to fibrinogen and ICAM-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

Platelet glycoprotein IIb/IIIa inhibitors: basic and clinical aspects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

Platelet-dependent thrombin generation after in vitro fibrinolytic treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

Differential antiplatelet effects of various glycoprotein IIb-IIIa antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

Vitronectin receptor (alpha(v)beta3) mediates platelet adhesion to the luminal aspect of endothelial cells: implications for reperfusion in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

Comparison of effects of clopidogrel versus ticlopidine on platelet function in patients undergoing coronary stent placement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

Clopidogrel as adjunctive antiplatelet therapy during coronary stenting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

Expression of Markers of Platelet Activation and the Interpatient Variation in Response to Abciximab

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: Implications for inhibition of the internal pool of GPIIb/IIIa receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

Antiplatelet agents in tissue factor-induced blood coagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

Paradoxical inhibition of fibrinogen binding and potentiation of alpha-granule release by specific types of inhibitors of glycoprotein IIb-IIIa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

Platelet activation as a potential mechanism of GP IIb/IIIa inhibitor-induced thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

Cytokines and endothelial cell biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

ICAM-1 a ligand for LFA-1-dependent adhesion of B, T and myeloid cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

Expression and inducibility of vascular adhesion receptors in development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

Role of platelets in restenosis after percutaneous coronary revascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

Influence of low- and high-dose aspirin treatment on thrombin generation in whole blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900368-5

Glycoprotein IIb/IIIa receptor blockade with coronary stent placement

7 January 2021

3

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(03)00368-5

28 March 2024

Identifiers